ZA847405B - Pyridine-soluble extract-refined detoxified endotoxin composition and use - Google Patents

Pyridine-soluble extract-refined detoxified endotoxin composition and use

Info

Publication number
ZA847405B
ZA847405B ZA847405A ZA847405A ZA847405B ZA 847405 B ZA847405 B ZA 847405B ZA 847405 A ZA847405 A ZA 847405A ZA 847405 A ZA847405 A ZA 847405A ZA 847405 B ZA847405 B ZA 847405B
Authority
ZA
South Africa
Prior art keywords
pyridine
soluble extract
detoxified endotoxin
endotoxin composition
refined detoxified
Prior art date
Application number
ZA847405A
Other languages
English (en)
Inventor
John Leonard Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of ZA847405B publication Critical patent/ZA847405B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA847405A 1983-09-23 1984-09-20 Pyridine-soluble extract-refined detoxified endotoxin composition and use ZA847405B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (1)

Publication Number Publication Date
ZA847405B true ZA847405B (en) 1985-05-29

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA847405A ZA847405B (en) 1983-09-23 1984-09-20 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Country Status (23)

Country Link
US (1) US4663306A (de)
JP (1) JPS60120817A (de)
KR (1) KR870000843B1 (de)
AT (1) AT385659B (de)
AU (1) AU566234B2 (de)
BE (1) BE900650A (de)
CA (1) CA1244765A (de)
CH (1) CH664897A5 (de)
DE (1) DE3434766A1 (de)
DK (1) DK446684A (de)
ES (1) ES8608872A1 (de)
FI (1) FI843716L (de)
FR (1) FR2552326B1 (de)
GB (1) GB2149301B (de)
HU (1) HU192585B (de)
IL (1) IL73034A (de)
IN (1) IN157240B (de)
IT (1) IT1179444B (de)
NL (1) NL8402902A (de)
NO (1) NO843776L (de)
NZ (1) NZ209635A (de)
SE (1) SE8404707L (de)
ZA (1) ZA847405B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
DE69429521T2 (de) * 1993-08-27 2002-07-18 Vetrepharm Inc Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
DK1003525T3 (da) 1997-08-05 2003-03-24 Bioniche Life Sciences Inc Præparat og fremgangsmåde til regulering af celleproliferation og celledød
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
CN1230184C (zh) * 1998-07-16 2005-12-07 东市郎 以细菌的菌体成分为有效成分的癌免疫治疗用制剂
EP1238070B1 (de) * 1999-12-13 2007-08-15 Bioniche Life Sciences Inc. Synthetische oligonukleotide die therapeutisch nützlich sind
JP4215429B2 (ja) * 1999-12-28 2009-01-28 バイオニケ ライフ サイエンシーズ インコーポレイテッド 癌治療におけるヒアルロン酸
NZ523535A (en) * 2000-07-11 2004-12-24 Bayer Ag Use of strains of the Parapoxvirus ovis against organ fibroses
AU2002236215B2 (en) * 2002-03-05 2008-03-06 Cell-Medicine, Inc. Solidified tissue immunological adjuvant
US20050250175A1 (en) * 2002-08-02 2005-11-10 Takehiko Nomura Bacterial cell wall skeleton component preparaion
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
WO2005023277A1 (fr) * 2003-09-05 2005-03-17 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. Composition a la base de squelettes de parois de cellules de nocardia rouge procede de preparation et son utilisation therapeutique pour traiter l'erosion cervicale
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
SG11201508092YA (en) 2013-04-18 2015-10-29 Immune Design Corp Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
BR112016029581B1 (pt) 2014-06-17 2022-05-03 Crown Laboratories, Inc Propionibacterium acnes geneticamente modificada, composição e seus usos
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (de) * 1972-06-20 1973-12-27
FR2269962B1 (de) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
AU566234B2 (en) 1987-10-15
IT1179444B (it) 1987-09-16
GB8423993D0 (en) 1984-10-31
KR870000843B1 (ko) 1987-04-25
DE3434766A1 (de) 1986-04-30
ES536167A0 (es) 1986-07-16
CA1244765A (en) 1988-11-15
AU3340084A (en) 1985-03-28
FI843716A0 (fi) 1984-09-21
FI843716L (fi) 1985-03-24
KR850002404A (ko) 1985-05-13
HU192585B (en) 1987-06-29
JPS60120817A (ja) 1985-06-28
NL8402902A (nl) 1985-04-16
IT8448894A0 (it) 1984-09-24
US4663306A (en) 1987-05-05
DK446684D0 (da) 1984-09-19
DK446684A (da) 1985-03-24
IN157240B (de) 1986-02-15
JPS6254775B2 (de) 1987-11-17
FR2552326A1 (fr) 1985-03-29
CH664897A5 (de) 1988-04-15
DE3434766C2 (de) 1987-05-14
BE900650A (fr) 1985-03-21
SE8404707L (sv) 1985-03-24
GB2149301A (en) 1985-06-12
FR2552326B1 (fr) 1988-05-13
GB2149301B (en) 1988-06-22
IL73034A (en) 1988-11-15
ES8608872A1 (es) 1986-07-16
AT385659B (de) 1988-05-10
NO843776L (no) 1985-03-25
SE8404707D0 (sv) 1984-09-20
HUT35521A (en) 1985-07-29
NZ209635A (en) 1989-01-27
ATA302384A (de) 1987-10-15

Similar Documents

Publication Publication Date Title
ZA847405B (en) Pyridine-soluble extract-refined detoxified endotoxin composition and use
DE3464100D1 (en) Electric-cable structure and its application
GB2145422B (en) Novel poly-esters their preparation and pharmacolgical use thereof
DE3567660D1 (en) Optionally porous intumescent compositions and their use
SG4890G (en) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols preparation and uses
DE3374569D1 (en) Siloxane-polyester compositions and use thereof
GB2161381B (en) Detoxified endotoxin compositions
IL71658A (en) 17-sulfonylmethylene-steroids and their preparation
DE3467898D1 (en) Fluorine-containing copolymer and composition containing the same
DE3367089D1 (en) 3-phenoxy-1-azetidinecarboxamides and their use and preparation
ZA842202B (en) Phenylaminobenzenealkanols and preparation
ZA893782B (en) Composition and use
DE3372983D1 (en) Radiation-sensible coating composition and its use
GB2147905B (en) Dye composition and use thereof
DE3562486D1 (en) Arginyl-3-carboxy-4-hydroxyanilide and their use
DE3471652D1 (en) Diurethane-diureas and use
IL73876A0 (en) Acylamino-mitosanes and their preparation
GB2126230B (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols preparation and use thereof
ZA846610B (en) Novel pyrazolylsulfonylureas and isoxazolylsulfonylureas
PH23727A (en) Imidazolylethoxyindanes and use as antithrombotic agents
DE3463048D1 (en) Furan-3-hydroxamates and their use
DE3466012D1 (en) Lubricant composition and its use
EP0134546A3 (en) Novel strains and use thereof
GR82496B (en) Compounds and use
GB2141121B (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols and preparation